IndiaMTF — home
Stock

LENSKART

Lenskart Solutions Limited
Health Technology

Daily Margin Trading Facility book for LENSKART across NSE and BSE, from 09 Dec 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹101 Cr
as of 10 Sep 2026
Rank in book
#376
162 days tracked
Share of book
0.07%
of the whole NSE + BSE book
Peak funded
₹386 Cr
on 12 May 2026
Largest single-day addition
+₹222 Cr
on 08 May 2026
Largest single-day unwind
−₹86 Cr
on 21 May 2026

NSE & BSE split

How LENSKART’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹99 Cr · 97.9%BSE ₹2 Cr · 2.1%

MTF vs Price

Margin-funded outstanding for LENSKART in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹681.75
as of 11 Sep 2026
Price, 30 days
+21.4%
adjusted for splits and bonuses
Delivery, 20-day avg
56.3%
of traded volume actually settled
Sessions to unwind
0.2
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹5+4.9%+4.0%
+66,039
−0.1%building as it falls
10 days−₹21−17.1%−19.8%
−4,18,453
+8.2%unwinding into strength
30 days+₹17+20.0%+6.3%
+1,00,266
+23.1%building into strength
90 days−₹40−28.3%−39.2%
−10,97,769
+40.3%unwinding into strength
180 days+₹77+323.5%+266.4%
+12,36,008
+33.3%building into strength
1 yearnot enough history
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where LENSKART has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

LENSKART — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026101+₹50.07%376
09 Sep 202696+₹10.06%397
08 Sep 202695−₹60.06%397
07 Sep 2026101−₹20.07%375
04 Sep 2026103+₹40.07%368
03 Sep 202699−₹40.07%379
02 Sep 2026102−₹20.07%363
01 Sep 2026104+₹30.07%358
31 Aug 2026102−₹260.07%364
28 Aug 2026127+₹60.08%299
27 Aug 2026122+₹40.08%313
26 Aug 2026117+₹60.08%323
25 Aug 2026111−₹20.07%335
24 Aug 2026113+₹90.07%330
21 Aug 2026104+₹10.07%353
20 Aug 2026103−₹40.07%356
19 Aug 2026107−₹10.07%345
18 Aug 2026108−₹370.07%336
17 Aug 2026146+₹60.10%249
14 Aug 2026140−₹110.10%261
13 Aug 2026151+₹570.10%244
12 Aug 202694+₹50.06%381
11 Aug 202689+₹20.06%405
10 Aug 202688+₹10.06%411
07 Aug 202687−₹40.06%416
06 Aug 202691+₹20.06%394
05 Aug 202689−₹10.06%401
04 Aug 202690−₹00.06%389
03 Aug 202690+₹30.06%384
31 Jul 202688—0.06%396

LENSKART within Health Technology

Ranked #18 of 61 funded Health Technology stocks, carrying 1.6% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
16BIOCON
Biocon Limited
₹1231.9%
17PPLPHARMA
Piramal Pharma Limited
₹1131.8%
18LENSKART
Lenskart Solutions Limited
₹1011.6%
19MANKIND
Mankind Pharma Limited
₹1001.6%
20ACUTAAS
Acutaas Chemicals Limited
₹1001.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.